UAB "Pharm House" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 1,063,396 |
| 210,991 |
| 291,583 |
| 248,302 |
| 49,266 |
| 47.50 |
| 23.35 |
| 489,528 |
| 244,502 |
| 78,582 |
| 649,989 |
| 2023 |
|---|
| 1,663,572 |
| 308,640 |
| 492,536 |
| 419,560 |
| 77,840 |
| 45.23 |
| 25.22 |
| 589,658 |
| 172,857 |
| 69,034 |
| 689,824 |
| 2024 |
|---|
| 2,203,946 |
| 367,324 |
| 635,235 |
| 539,645 |
| 89,941 |
| 53.80 |
| 24.49 |
| 894,008 |
| 513,615 |
| 198,056 |
| 1,199,435 |
Register and
explore Okredo data| 2024 |
|---|
| 2,203,946 |
| 367,324 |
| 635,235 |
| 539,645 |
| 89,941 |
| 53.80 |
| 24.49 |
| 894,008 |
| 513,615 |
| 198,056 |
| 1,199,435 |
Register and
explore Okredo data2024
Turnover (€)
2,203,946 €
32 % *
Sales per employee (€)
367,324 €19 % *
Profit before tax (€)
635,235 €29 % *
Net Profit (€)
539,645 €29 % *
Profit per employee (€)
89,941 €16 % *
Total profitability (%)
53.80 %18.95 % *
Net profitability (%)
24.49 %
-2.89 % *
Equity (€)
894,008 €52 % *
Amounts Payable And Liabilities (€)
513,615 €
197 % *
Non-current Assets (€)
198,056 €187 % *
CurrentAssets (€)
1,199,435 €74 % *